APA (7th ed.) Citation

NA, S., L, J., A, A., V, V., NH, L., PH, C., . . . HS, P. (2023). Utilization and Survival Impact of Hypofractionated Radiotherapy in Stage I Non-small Cell Lung Cancer. American journal of clinical oncology, 46(2), 66. https://doi.org/10.1097/COC.0000000000000974

Chicago Style (17th ed.) Citation

NA, Saeed, Jin L, Amini A, Verma V, Lester-Coll NH, Chen PH, Decker RH, and Park HS. "Utilization and Survival Impact of Hypofractionated Radiotherapy in Stage I Non-small Cell Lung Cancer." American Journal of Clinical Oncology 46, no. 2 (2023): 66. https://doi.org/10.1097/COC.0000000000000974.

MLA (9th ed.) Citation

NA, Saeed, et al. "Utilization and Survival Impact of Hypofractionated Radiotherapy in Stage I Non-small Cell Lung Cancer." American Journal of Clinical Oncology, vol. 46, no. 2, 2023, p. 66, https://doi.org/10.1097/COC.0000000000000974.